Brief: Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023
Dec 6 (Reuters) - Celularity Inc CELU.O :
* CELULARITY REPORTS OVER SEVENFOLD GROWTH IN NET PRODUCT
SALES THROUGH THIRD QUARTER 2024 COMPARED TO THIRD QUARTER 2023
* CELULARITY INC: FILED QUARTERLY REPORT ON FORM 10-Q FOR
PERIOD
ENDED SEPT 30, & NOW CURRENT WITH QUARTERLY REPORT FILINGS
Source text: ID:nGNXfGbsh
Further company coverage: CELU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celularity
See all newsU.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Celularity hits over 4-month high on deal to manufacture MuseCell's cell therapy platform
Celularity rises on deal to manufacture MuseCell's cell therapy platform
Brief: Celularity And MuseCell Innovations® Announce U.S. Manufacturing Collaboration For The Dezawa Musecell® Platform